India’s Bharat Biotech says its Covaxin booster dose offers long-term protection | Inquirer News

India’s Bharat Biotech says its Covaxin booster dose offers long-term protection

/ 10:28 PM January 08, 2022

COVID-19 vaccination in New Delhi

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech’s COVID-19 vaccine called Covaxin during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, Jan. 16, 2021. (REUTERS)

India’s Bharat Biotech said on Saturday a booster dose of its COVID-19 vaccine Covaxin offered long-term protection from severe disease in a trial.

The company said a booster dose was given to trial participants six months after they received their second dose.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.